Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

A Small Molecule, Shikonin, Dually Functions As a Proteasome Inhibitor and a Necroptosis Inducer In Multiple Myeloma Cells

Naoko Wada, MD, Yawara Kawano, MD, PhD, Shiho Fujiwara, MD, Yoshitaka Kikukawa, MD, PhD, Yutaka Okuno, MD, PhD, Hiroaki Mitsuya, MD, PhD, Hiroyuki Hata, MD, PhD

Blood (2013) 122 (21): 3172.

https://doi.org/10.1182/blood.V122.21.3172.3172

Published: 2013

Journal Articles

Lactate Is a Crucial Energy Source For Multiple Myeloma (MM) Cells In Bone Marrow Microenvironment

Shiho Fujiwara, MD, Naoko Wada, MD, Yawara Kawano, MD, PhD, Yoshitaka Kikukawa, MD PhD, Hiroaki Mitsuya, MD PhD, Hiroyuki Hata, MD, PhD

Blood (2013) 122 (21): 3109.

https://doi.org/10.1182/blood.V122.21.3109.3109

Published: 2013

Journal Articles

Production of TRAIL by Multiple Myeloma Cells: a Potential Prediction Marker for Skeletal-Related Events

Yawara Kawano, Shikiko Ueno, Masahiro Abe, MD, Yoshitaka Kikukawa, Hiromichi Yuki, Kenichi Iyama, Yutaka Okuno, MD, PhD, Hiroaki Mitsuya, Hiroyuki Hata, MD, PhD

Blood (2010) 116 (21): 2975.

https://doi.org/10.1182/blood.V116.21.2975.2975

Published: 2010

Journal Articles

CD125-Expressing Myeloma: A Subgroup of Multiple Myeloma (MM) with Immature Phenotype, Endoplasmic Reticulum Stress Response and Low Sensitivity to Bortezomib

Yawara Kawano, Yoshitaka Kikukawa, Miki Nakamura, Yutaka Okuno, MD, PhD, Hiromichi Yuki, Shiho Fujiwara, Hiroaki Mitsuya, Hiroyuki Hata, MD, PhD

Blood (2010) 116 (21): 616.

https://doi.org/10.1182/blood.V116.21.616.616

Published: 2010

Journal Articles

Treatment of MGUS by Hesperetin, potentially Delaying/Blocking the Conversion of MGUS to Symptomatic Myeloma.

Yoshitaka Kikukawa, Hiroaki Mitsuya, Hiroyuki Hata, MD, PhD

Blood (2009) 114 (22): 1885.

https://doi.org/10.1182/blood.V114.22.1885.1885

Published: 2009

Journal Articles

Upregulation of TRAIL in Myeloma Cells Correlates with Skeletal-Related Events.

Yawara Kawano, Shikiko Ueno, Yutaka Okuno, Yoshitaka Kikukawa, Hiroaki Mitsuya, Hiroyuki Hata, MD, PhD

Blood (2009) 114 (22): 2844.

https://doi.org/10.1182/blood.V114.22.2844.2844

Published: 2009

NARROW

A Small Molecule, Shikonin, Dually Functions As a Proteasome Inhibitor and a Necroptosis Inducer In Multiple Myeloma Cells

Lactate Is a Crucial Energy Source For Multiple Myeloma (MM) Cells In Bone Marrow Microenvironment

Production of TRAIL by Multiple Myeloma Cells: a Potential Prediction Marker for Skeletal-Related Events

CD125-Expressing Myeloma: A Subgroup of Multiple Myeloma (MM) with Immature Phenotype, Endoplasmic Reticulum Stress Response and Low Sensitivity to Bortezomib

Treatment of MGUS by Hesperetin, potentially Delaying/Blocking the Conversion of MGUS to Symptomatic Myeloma.

Upregulation of TRAIL in Myeloma Cells Correlates with Skeletal-Related Events.

Email alerts

ASH Publications

American Society of Hematology

A Small Molecule, Shikonin, Dually Functions As a Proteasome Inhibitor and a Necroptosis Inducer In Multiple Myeloma Cells

Lactate Is a Crucial Energy Source For Multiple Myeloma (MM) Cells In Bone Marrow Microenvironment

Production of TRAIL by Multiple Myeloma Cells: a Potential Prediction Marker for Skeletal-Related Events

CD125-Expressing Myeloma: A Subgroup of Multiple Myeloma (MM) with Immature Phenotype, Endoplasmic Reticulum Stress Response and Low Sensitivity to Bortezomib

Treatment of MGUS by Hesperetin, potentially Delaying/Blocking the Conversion of MGUS to Symptomatic Myeloma.

Upregulation of TRAIL in Myeloma Cells Correlates with Skeletal-Related Events.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only